Thomas Jefferson University researchers developed an AutoML model that distinguishes pituitary macroadenomas from parasellar meningiomas on MRI with over 97% accuracy.
Key Details
- 1AutoML model trained to classify pituitary macroadenomas vs. parasellar meningiomas on preoperative MRI.
- 2Achieved 97.55% overall accuracy, with sensitivities of 97% (macroadenoma) and 98.41% (meningioma), and specificities of 98.96% and 95.53%, respectively.
- 3External validation conducted on 959 additional MRI images.
- 4Model allows different confidence thresholds, aiding both community screening and tertiary centers.
- 5First reported use of AutoML for this specific neuro-oncology imaging task.
- 6The study published in Otolaryngology–Head and Neck Surgery (Dec 2025); presented at AAO-HNSF 2025.
Why It Matters
Accurate, non-invasive differentiation of similar-appearing benign brain tumors using MRI can improve preoperative planning, reduce surgical risks, and ensure patients receive optimal treatment. This demonstrates AutoML's potential to streamline diagnostic AI development and deployment in neuro-radiology.
Source
EurekAlert
Related News
•EurekAlert
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
•EurekAlert
AI Model Accurately Flags Brain MRI Abnormalities, Eases Radiologist Burden
A new AI model can accurately flag brain abnormalities in MRI scans, potentially streamlining triage and diagnosis for radiologists.
•EurekAlert
UCLA Researchers Present AI, Blood Biomarker Advances at SABCS 2025
UCLA Health researchers unveil major advances in breast cancer AI pathology, liquid biopsy, and biomarker strategies at the 2025 SABCS.